Description: Uni-Bio Science Group Limited, an investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People's Republic of China. It operates in Chemical Pharmaceutical Products, Biological Pharmaceutical Products, and Pipeline Products. The company provides GeneTime, a prescription biological drug for wound healing; GeneSoft, a therapeutic drug for dry eye syndrome, corneal damage, and post-operative healing; Pinup, a voriconazole tablet to treat severe fungal infections; and Boshutai, a small molecule drug to treat diabetes. It is also developing prescription drugs, including rExendin-4 (Uni-E4) for Type 2 diabetes; and rhPTH 1-34 (Uni-PTH) for the treatment of osteoporosis in postmenopausal women, as well as Uni-GLP, a GLP-1 agent for the treatment of Type 2 diabetes. In addition, the company is involved in the distribution of hydrogel wound dressing for post-skin injury and minimally invasive surgery wound healing. Uni-Bio Science Group Limited was incorporated in 2001 and is headquartered in Sha Tin, Hong Kong.
Home Page: www.uni-bioscience.com
No. 20 Science Park East Avenue
Sha Tin,
Hong Kong
Phone:
852 3102 3232
Officers
| Name | Title |
|---|---|
| Mr. Kingsley Leung AHKIoD, CFA, MSc | Executive Chairman of the Board |
| Mr. Zhi Gang Zhao CPA, MSc | CEO & Executive Director |
| Mr. Dawei Chen EMBA | Executive Vice Chairman of the Board |
| Mr. Kai Du | Financial Controller |
| Ms. Wei Tian | Head of HR & Administration Department |
| Mr. Wen Du An | Head of Marketing & Sales |
| Dr. Ya Lei Wen | Head of Manufacture Department |
| Mr. HuaNan Zhao | Head of Medicine & Registration Department |
| Ms. Jing Li | Head of R&D Department |
| Ms. Wing Yan Ho A.C.I.S., A.C.S., ACS (PE), ACS(PE), P.E. | Company Secretary |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 458 |